
SOTS 2nd Hour: Stocks Under Pressure, Lilly’s Next Big Bet, & Oracle CEO Safra Katz 2/20/25
Squawk on the Street
00:00
Market Volatility and Pharmaceutical Innovations
This chapter analyzes the stock market's current volatility, focusing on earnings expectations and the impact of tariffs and macroeconomic factors. It also highlights Eli Lilly's breakthrough with Zepbound in obesity treatments, featuring expert insights on the future of healthcare advancements.
Transcript
Play full episode